HealthcheX® fFN Rapid Test
HealthcheX® fFN is an immunochromatographic rapid test that can detect fFN at 50ng/mL and above, with a high sensitivity and specificity. It can be performed by a vaginal swab to estimate the risk of preterm labour (PTL) by measuring the fFN in vaginal fluid.
- Tests can be read in 10 minutes
- No refrigeration required
- Can be used almost anywhere to detect if preterm delivery is likely to occur in pregnant women between 24 and 34 weeks gestation
- Relative Sensitivity: 98.1% (95%Cl:*93.2%-99.8%)
- Relative Specificity: 98.7% (95%Cl:*95.3%-99.8%)
- Overall Accuracy: 98.4% (95%Cl:*96.0%-99.6%)
*Confidence Intervals
BIOSYNEX Premaquick
By combining markers of myometrial activation (native IGFBP-1), cervical maturity (total IGFBP-1) and Inflammation (IL-6), the PREMAQUICK® test integrates the main pathogenetic mechanisms responsible for premature delivery and allows to obtain high positive and negative predictive capabilities of delivery at 7 and 14 days.
- Rapid test predicting preterm birth
- Sample Type: Vaginal Swab
- Time to get result: 10 minutes
- Content: 10 tests
- Test format: Cassette
- Specificity: ≤ 7 days 91% ≤14 days 97%
- Sensitivity: ≤7 days 94% ≤14 days 94%
Labpad Evolution
LabPad® Evolution is an ultra-portable device weighing only 270g that utilises unique and patented technology with an evolutive panel of tests for monitoring and diagnosis at the point of care.
• CRP, D-Dimer, INR
• Coming soon in 2025: Ksmart® Fibrinogen assay (contact us for details)
• Footprint not much larger than a mobile phone (17.2cm x 7.4cm x 4.6cm max)
• Simple and intuitive to use by healthcare professionals
• Internal memory stores 1000 test results
• Connection via Bluetooth to smartphone and tablet applications
ProciseDx™
The ProciseDx™ is a small desktop analyser weighing about 4.5 kg with four assays that support the monitoring of chronic inflammatory bowel disease at the point of care.
• CRP, Infliximab, Adalimumab and Faecal Calprotectin assays
• Quantitative results in less than 5 minutes
• Capillary whole blood, venous blood, serum or stool samples
• Intuitive and easy self-administered stool sampling at home
• Time-resolved fluorescence (TR-FRET) and Lumiphore® technology
• Lab-comparable sensitivity and specificity
• Internal controls - no calibration or maintenance required
• Internal and external barcode reading system
• Intuitive interface with 7 colour touch screen
• Data transfer via HL7 or USB
Quo-Test
Quo-Test is a lab-accurate and easy-to-use Glycated Haemoglobin analyser that is an excellent tool in the diagnosis and management of diabetic patients at the point of care.
• HbA1c test results within 4 minutes
• Sample required is only 4µl finger prick capillary or venous blood
• Step-by-step instructions on display
• Boronate Affinity methodology
• Unaffected by Hb variants
• Traceable to IRCC referencing method
• Compact ergonomic design weighing only 1.3kg
• Only one barcode scan per lot of cartridges required
• Stores up to 7000 test results
• EFK link software for LIS connection
AFIAS Range
The AFIAS range of products is a unique integrated sample-to-answer point of care testing system featuring up to 6 parallel tests of differing parameters.
• Multi-analyte testing with over 40 markers for Cardiac, Cancer, Diabetes, Hormone, Autoimmune, Organ Function, Therapeutic Drug Monitoring, Molecular Diagnostics, and other tests including Vitamin D and Ferritin.
• Fast and high sensitivity results within an average time of 10 minutes rivals full-featured systems in commercial labs
• Bright, easy to read touchscreen interface for rapid menu navigation
• Results can be printed, exported to USB, and/or uploaded to the user’s internal network
• Compact size makes it ideal for use in GP Surgeries, Accident and Emergency Ward, Community Health Clinic or Laboratory
AFIAS Assays:
CardioChek® Plus
Built on the success of the CardioChek® PA system, which was the first handheld analyser to provide a full Lipid Profile using a simple finger-stick sample of blood, the CardioChek® Plus analyser is a fast and accurate system that performs a full Lipid profile and glucose simultaneously at the Point of Care, with results in as little as 90 seconds.
• Tests Total Cholesterol (TC), High Density Lipid Cholesterol (HDL), Triglycerides, and Glucose (mmol/L).
• Can also calculate LDL Cholesterol, TC/HDL Ratio, LDL/HDL Ratio and Non-HDL Cholesterol values
• Only a small finger-prick blood sample required
• Meets NCEP guidelines for accuracy and precision
• FCC and ISO certified for wireless communications
• CRMLN-certified for CHOL and HDL tests.
Skyla HB1 Clinical Chemistry Analyser
Portable and compact, the Skyla™ HB1 Clinical Chemistry Analyser offers a cost efficient and time saving solution to your clinical or scientific needs. This in-vitro clinical chemistry diagnostic tool is compact, portable, and reports rapid results. It utilises precision photometric measurement technology, combined with single-use disposable reagent discs which contain a set of dry assay reagents that are used in the quantitative testing of various biomarkers in the blood sample.
In three simple steps, the Skyla™ HB1 provides fully automatic procedures to test and analyse up to 15 parameters simultaneously using a small volume (200 µL) of blood, serum or plasma to give reproducible and reliable results.
- Store up to 50,000 analysis results
- 5 inch colour LCD Touch Screen
- Built-in thermal printer or external USB printer (PCL 3GUI)
- USB Type A (host) for external USB printer, USB flash drive (FAT) or external barcode scanner
- RS232 serial port or RJ45 (LAN) for data transmission to PC
- Dimensions: 233 (W) x 285 (D) x 300 (H) mm
- Weight: 5.5kg
Multi Analyte Testing
The Skyla™ HB1 Clinical Chemistry Analyser can test a broad range of analytes thereby making it viable to use in different clinical settings. Built-in calibration, internal quality control, and dry chemical test reagents ensure the quantitative results are reproducible and accurate.
We need your consent to load the translations
We use a third-party service to translate the website content that may collect data about your activity. Please review the details in the privacy policy and accept the service to view the translations.